Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00259896 | In-patient Study in Patients With Type 2 Diabetes Mellitus | PHASE1 | COMPLETED | 30 | — | — | Oct 1, 2005 | - | Jun 4, 2012 | - | — |
| Name | Type | Description |
|---|---|---|
| exenatide | DRUG | - |
Inclusion Criteria: * have type 2 diabetes mellitus that has been diagnosed for at least three months * must be taking either (1) no medication for their diabetes or (2) taking metformin, a sulfonylurea, or metformin and a sulfonylurea * must be willing to wash-out of these medications for 14 days ...